Vericel (VCEL) Assets Growth (3y) (2013 - 2026)
Powered by 
Analysis
Vericel (VCEL) Assets Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.26 Bn | 9.41 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.06 Bn | 3.06 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.68 Bn | 2.68 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.34 Bn | 1.55 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Taysha Gene Therapies | 1.99 Bn | 1.99 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.41% |
| Mar 31, 2026 | 22.36% |
| Dec 31, 2025 | 21.36% |
| Sep 30, 2025 | 22.26% |
| Jun 30, 2025 | 21.18% |
| Mar 31, 2025 | 20.90% |
| Dec 31, 2024 | 21.09% |
| Sep 30, 2024 | 20.32% |
| Jun 30, 2024 | 19.30% |
| Mar 31, 2024 | 19.03% |
| Dec 31, 2023 | 19.82% |
| Sep 30, 2023 | 26.41% |
| Jun 30, 2023 | 28.43% |
| Mar 31, 2023 | 20.83% |
| Dec 31, 2022 | 21.23% |
| Sep 30, 2022 | 21.72% |
| Jun 30, 2022 | 24.84% |
| Mar 31, 2022 | 19.38% |
| Dec 31, 2021 | 27.10% |
| Sep 30, 2021 | 21.66% |